本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aura Biosciences, Inc.

5.05
-0.4250-7.77%
成交量:10.78万
成交额:56.94万
市值:2.54亿
市盈率:-2.88
高:5.64
开:5.54
低:5.03
收:5.47
数据加载中...
2025/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities